热门资讯> 正文

Terns Pharmaceutical股价为每股40美元

2025-12-10 15:20

Terns Pharmaceuticals, Inc.(TERN) 0

Terns Pharmaceuticals (TERN) priced an upsized underwritten public offering of 16.25M shares at a public offering price of $40.00 per share.
The gross proceeds from the offering are expected to be $650M.
The underwriters have a 30-day option to purchase up to an additional ~2.44M shares.
The offering is expected to close on December 11, 2025.
The stock price traded ~1.2% higher on Tuesday during after-hours trading.

More on Terns Pharmaceuticals

Terns Pharmaceuticals: CML Data Blows Wall Street Away - Again
Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia Transcript
Terns Pharmaceuticals: GLP-1 Obesity Drug Cut Warrants Downgrade To 'Hold' Rating
Terns Pharmaceuticals proposes $400M equity offering
Terns Pharmaceuticals GAAP EPS of -$0.27

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。